AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GILEAD SCIENCES, INC. Director's Dealing 2017

May 12, 2017

29828_dirs_2017-05-12_4f8c57dc-50ed-4c3d-85b1-b87952b0be4c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-05-10

Reporting Person: Kramer Kelly A. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-10	Non-qualified Stock Option (Right to Buy)	$66.92	A	10376	Acquired	2027-05-10	Common Stock (10376)	Direct
2017-05-10	Restricted Stock Unit	$	A	2241	Acquired		Common Stock (2241)	Direct

Footnotes

F1: Options vest quarterly over the first year of service upon the earlier of May 9, 2018, or the day immediately preceding the next regular annual stockholders meeting.

F2: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3: 100% of the restricted stock units will vest upon the earlier of May 9, 2018, or the day immediately preceding the next regular annual stockholders meeting.